首页> 外国专利> Bifunctional molecules with Recruitment activity of Antibodies and initial Inhibitory activity against human immunodeficiency virus

Bifunctional molecules with Recruitment activity of Antibodies and initial Inhibitory activity against human immunodeficiency virus

机译:具有抗体募集活性和对人免疫缺陷病毒的初始抑制活性的双功能分子

摘要

The present invention is directed to new bifunctional compounds and methods for treating HIV infections. The bifunctional small molecules, generally referred to as ARM-HI's, function through orthogonal pathways, by inhibiting the gp120-CD4 interaction, and by recruiting anti-DNP antibodies to gp120-expressing cells, thereby preventing cell infection and spread of HIV. It has been shown that ARM-HI's bind to gp120 and gp-120 expressing cells competitively with CD4, thereby decreasing viral infectivity as shown by an MT-2 cell assay, the binding leading to formation of a ternary complex by recruiting anti-DNP antibodies to bind thereto, the antibodies present in the ternary complex promoting the complement-dependent destruction of the gp120-expressing cells. Compounds and methods are described herein.
机译:本发明涉及用于治疗HIV感染的新的双功能化合物和方法。双功能小分子(通常称为ARM-HI)通过抑制gp120-CD4相互作用,并通过向表达gp120的细胞募集抗DNP抗体,通过正交途径起作用,从而防止细胞感染和HIV传播。已经显示,ARM-HI与CD4竞争性结合至表达gp120和gp-120的细胞,从而降低了病毒的感染性,如MT-2细胞分析所示,该结合通过募集抗DNP抗体导致三元复合物的形成为了与之结合,存在于三元复合物中的抗体促进表达gp120的细胞的补体依赖性破坏。本文描述了化合物和方法。

著录项

  • 公开/公告号CO6801635A2

    专利类型

  • 公开/公告日2013-11-29

    原文格式PDF

  • 申请/专利权人 YALE UNIVERSITY;

    申请/专利号CO20130138546

  • 发明设计人 SPIEGEL DAVID;PARKER CHRISTOPHER;

    申请日2013-06-07

  • 分类号C07D405/14;

  • 国家 CO

  • 入库时间 2022-08-21 15:58:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号